Docetaxel hydrate induces apoptosis and suppresses tumorigenesis of oral Burkitt’s lymphoma cells (in vitro and in vivo studies)

Supriatno Supriatno

Abstract


Introduction: Burkitt’s lymphoma (BL) is one of the tumours with high malignancy and rapid cell growth, derived from B-cell lymphoma. BL typically found in children at dengue-endemic and HIV-AIDS areas with low socioeconomic levels. This study was aimed to analyse the induction of apoptosis and the suppression of tumorigenesis of oral Burkitt’s lymphoma (Raji) cells using docetaxel hydrate in vitro and in vivo. Methods: In the present study, the pure experimental laboratory with post-test only control group design was carried out. Raji cell cultures were incubated with docetaxel hydrate by doses of 0, 1.25 x 10-2, 2.5 x 10-2, and 5.0 x 10-2 M; and IC50 carboplatin (3.1 x 10-6 M) as a positive control. Induction of apoptotic was analysed by double staining of acridine orange-ethidium bromide. Tumorigenesis assay was performed by inoculating Raji cells in nude mice flanks at 1 x 106 cells/mice. Tumour treatment was delivered by various doses of docetaxel hydrate peroral. Results: Apoptosis cells were significantly increased in Raji cells treated with docetaxel hydrate by doses of 2.5 x 10-2 and 5.0 x 10-2 M. The tumour volume in mice given doses of 2.5 x 10-2 and 5.0 x 10-2 M was markedly decreasing compared to control (dose of 0). Conclusion: Docetaxel hydrate has a high antitumour potency by inhibiting tumorigenesis and increasing apoptosis of Burkitt’s lymphoma cells.

 

Keywords: Docetaxel hydrate, double staining, Burkitt’s lymphoma cell, apoptosis, tumorigenesis


Keywords


Docetaxel hydrate, double staining, Burkitt’s lymphoma cell, apoptosis, tumorigenesis

Full Text:

PDF

References


Gopal S, Gross TG. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood. 2018; 132(3): 254-63. DOI: 10.1182/blood-2018-04-844472

God JM, Haque A. Burkitt Lymphoma: Pathogenesis and Immune Evasion. J Oncol. 2010; 2010: 1-14. DOI: 10.1155/2010/516047

Salamon D, Adori M, He M, Bonelt P, Severinson E, Kis LL, et al. Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt’s lymphoma. Cytokine. 2012; 57(3): 360-71. DOI: 10.1016/j.cyto.2011.12.001

Rowe M, Fitzsimmons L, Bell AI. Epstein-Bar virus and Burkitt’s lymphoma. Chin J Cancer. 2014; 33(12): 609-19. DOI: 10.5732/cjc.014.10190

Nafianti S, Windiastuti E, Gatot D. 2008. Gambaran Limfoma Burkitt di Departemen Ilmu Kesehatan Anak RSUP Cipto Mangunkusumo Jakarta. Sari Pediatri. 2008; 10(1): 47-52. DOI: 10.14238/sp10.1.2008.47-52

Supriatno. Docetaxel hidrat menghambat proliferasi dan metastasis sel kanker oral melalui induksi protein Maspin. J Dent Ind. 2008; 15(1): 2-7. DOI: 10.14693/jdi.v15i1.77

O’Neill AJ, Prencipe M, Dowling C, Fan Y, Mulrane L, Gallagher WM, et al. Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. Mol Cancer. 2011; 10: 126. DOI: 10.1186/1476-4598-10-126

Zhang X, Zhang S, Liu Y, Liu J, Ma Y, Zhu Y, et al. Effects of the combination of RAD001 and docetaxel on breast cancer stem cells. Eur J Cancer. 2012; 48(10): 1581-92. DOI: 10.1016/j.ejca.2012.02.053

Wada Y, Yoshida K, Suzuki T, Mizuiri H, Konishi K, Ukon K, et al. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines. Int J Cancer. 2006; 119(4): 783-91. DOI: 10.1002/ijc.21879

Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, Hersey P. Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther. 2007; 6(2): 752-61. DOI: 10.1158/1535-7163.MCT-06-0564

Friedlander RM. Apoptosis and caspases in neurodegenerative disease. N Engl J Med. 2003; 348(14): 1365-75. DOI: 10.1056/NEJMra022366

Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol. 2007; 35(4): 495-516. DOI: 10.1080/01926230701320337

Supriatno, Harada K, Hoque MO, Bando T, Yoshida H, Sato M. Overexpression of p27Kip1 induces growth arrest and apoptosis in an oral cancer cell line. Oral Oncol. 2002; 38(7): 730-6. DOI: 10.1016/S1368-8375(02)00011-8

Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry. 2006; 11(3): 241–51. DOI: 10.1038/sj.mp.4001758

Croce CM. Oncogenes and cancer. N England J Med. 2008; 358(5): 502–11. DOI: 10.1056/NEJMra072367

Omotehara F, Kawamata H, Uchida D, Hino S, Nakashiro K, Fujimori T. Vesnarinone, a differentiation inducing drug, directly activates p21waf1 gene promoter via Sp1 sites in a human salivary gland cancer cell line. Br J Cancer. 2002; 87(9): 1042-6. DOI: 10.1038/sj.bjc.6600592

Supriatno, Harada K, Yoshida H, Sato M. 2005. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells. Int J Oncol 27: 627-635.

Baker SD, Sparreboom A, Varweij J. 2006. Clinical Pharmacokinetics of Docetaxel. Recent Developments. Clin Pharmacokinet 45 (3): 235-252.

Lyseng-Williamson KA, Fenton C. 2005. Docetaxel: a review of its use in metastatic breast cancer. Drugs 65: 2513-2531.

Munkarah AR, Ali-Fehmi R, Jiang JZ, Elhammady E, Malone JM, Saed GM. 2007. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer. Anticancer Drug 18: 889-896.

Tao J, Xu J, Chen F, Xu B, Gao J, Hu Y. 2017. Folate acid-Cyclodextrin/Docetaxel induces apoptosis in KB cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo. Eur J Pharm Sci. S0928-0987(17): 30614-20.

Han TD, Shang DH, Tian Y. 2016. Docetaxel enhances apoptosis and G2/M cell cycle arrest by suppressing mitogen-activated protein kinase signaling in human renal clear cell carcinoma. Genet Mol Res.15(1): 1-10.

Harada K, Supriatno, Kawaguchi S, Onoue T, Kawashima Y, Yoshida H and Sato M.2005. High antitumor activity using intratumoral injection of plasmid DNA with mutant-type p27Kip1 gene following in vivo electroporation. Oncol Rep 13: 201-206.

Supriatno, Harada K, Kawaguchi S, Yoshida H, Sato M. 2003. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line. Oncol Rep 10:527-532.

Ichite N, Chougule MB, Jackson T, Fulzele SV, Safe S, Singh M. 2009. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res. 15(2):543-52

Gaoe H, Pang Z, Pan S, Cao S, YangZ, Chen C, Jiang X. 2012. Anti-glioma Effect and Safety of Docetaxel-loaded Nanoemulsion. Arch Pharm Res. 35(2):333-41

Huang GC, Liu SY, Lin MH, Kuo YY, Liu YC. 2004. The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma. Jpn J Clin Oncol. 34(9): 499-504




DOI: https://doi.org/10.24198/pjd.vol31no1.18102

Refbacks

  • There are currently no refbacks.


Visitor Stat

Creative Commons License
Padjadjaran Journal of Dentistry is licensed under Creative Commons Attribution 4.0 International License